Ethacrynic acid improves the antitumor effects of irreversible epidermal growth factor receptor tyrosine kinase inhibitors in breast cancer

Prolonged treatment of breast cancer with epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) often results in acquired resistance and a narrow therapeutic index. One strategy to improve the therapeutic effects of EGFR TKIs is to combine them with drugs used for other clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Bing, Huang, XinPing, Hu, YunLong, Chen, TingTing, Peng, BoYa, Gao, NingNing, Jin, ZhenChao, Jia, TieLiu, Zhang, Na, Wang, ZhuLin, Jin, GuangYi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295410/
https://www.ncbi.nlm.nih.gov/pubmed/27487128
http://dx.doi.org/10.18632/oncotarget.10846

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295410/
https://www.ncbi.nlm.nih.gov/pubmed/27487128
http://dx.doi.org/10.18632/oncotarget.10846

Ejemplares similares